Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (161-170 of 531) with videos related to

Pageof 54
Sort By:
Antimicrobial Agents and Chemotherapy|November 26, 1997
Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection modelH H Houlihan, R C Mercier, M J Rybak
Antimicrobial Agents and Chemotherapy|November 26, 1997
In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faeciumR C Mercier, S R Penzak, M J Rybak
The Annals of Pharmacotherapy|March 13, 1998
Trimethoprim/sulfamethoxazole-induced tremor in a patient with AIDSR S Slavik, M J Rybak, S A Lerner
The Journal of Antimicrobial Chemotherapy|October 8, 1999
The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection modelJ R Aeschlimann, G W Kaatz, M J Rybak
The Journal of Antimicrobial Chemotherapy|June 2, 2007
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategiesWarren E Rose, Michael J Rybak, Glenn W Kaatz
Cancer|September 1, 1991
A case of adenocarcinoma of the lung associated with a neck mass and hypercalcemiaV I Benisovich, B J Rybak, F A Ross
Drug Intelligence & Clinical Pharmacy|September 1, 1982
Treatment of pseudomonal endocarditis with high-dose aminoglycosidesM J Rybak, S C Boike, P W Bush
Antimicrobial Agents and Chemotherapy|October 3, 1998
Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetationsJ R Aeschlimann, M J Zervos, M J Rybak
American Journal of Clinical Pathology|October 1, 1975
A pulmonary fungus ball produced by Cladosporium cladosporioidesK J Kwon-Chung, I S Schwartz, B J Rybak
Antimicrobial Agents and Chemotherapy|March 18, 2000
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strainsM J Rybak, E Hershberger, T Moldovan, et al.
Pageof 54

Showing results (161-170 of 531) with videos related to

Sort By:
Pageof 54
Antimicrobial Agents and Chemotherapy|November 26, 1997
Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection modelH H Houlihan, R C Mercier, M J Rybak
Antimicrobial Agents and Chemotherapy|November 26, 1997
In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faeciumR C Mercier, S R Penzak, M J Rybak
The Annals of Pharmacotherapy|March 13, 1998
Trimethoprim/sulfamethoxazole-induced tremor in a patient with AIDSR S Slavik, M J Rybak, S A Lerner
The Journal of Antimicrobial Chemotherapy|October 8, 1999
The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection modelJ R Aeschlimann, G W Kaatz, M J Rybak
The Journal of Antimicrobial Chemotherapy|June 2, 2007
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategiesWarren E Rose, Michael J Rybak, Glenn W Kaatz
Cancer|September 1, 1991
A case of adenocarcinoma of the lung associated with a neck mass and hypercalcemiaV I Benisovich, B J Rybak, F A Ross
Drug Intelligence & Clinical Pharmacy|September 1, 1982
Treatment of pseudomonal endocarditis with high-dose aminoglycosidesM J Rybak, S C Boike, P W Bush
Antimicrobial Agents and Chemotherapy|October 3, 1998
Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetationsJ R Aeschlimann, M J Zervos, M J Rybak
American Journal of Clinical Pathology|October 1, 1975
A pulmonary fungus ball produced by Cladosporium cladosporioidesK J Kwon-Chung, I S Schwartz, B J Rybak
Antimicrobial Agents and Chemotherapy|March 18, 2000
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strainsM J Rybak, E Hershberger, T Moldovan, et al.
Pageof 54